This week CapSite published their 2012 Laboratory IS Study. Close to 300 U.S. hospitals shared their plans around LIS investment, including primary drivers behind the decision-making process.
- 19% of U.S. Hospitals Plan to Replace their LIS
- 47% of U.S. Hospitals List Efficiency Improvements as the Primary Driver for Investing in an LIS
Burlington, VT, July 3, 2012 – CapSite™ announces the release of the 2012 U.S. Laboratory Information System (LIS) Study. The 2012 LIS study is the most recent in a series of CapSite strategic industry reports that have evaluated the impact of the HITECH Act focus on stimulating the adoption of Electronic Health Record (EHR) and Health Information Exchange (HIE) solutions.
The 2012 LIS study represents unique Voice of Customer (VOC) insight from more than 290 hospitals on the market opportunity, vendor mind share and vendor market share across the U.S.
“Our study indicates that efficiency improvements are by far the primary driver behind hospitals decision to replace their current LIS. Additionally, we found that the most important LIS product attribute that hospital buyers are looking for in a new LIS, is integration with their current EHR.” says CapSite Sr. VP and GM, Gino Johnson.
Vendor Market Share and Mind Share coverage includes:
Abbott, Allscripts, Beckman Coulter, Cerner, CPSI, Epic, Fisher Healthcare, GE, Healthland, HMS, McKesson, Meditech, Orchard Software, Roche, SCC Softlab, Siemens, Sunquest and Sysmex
The CapSite database provides unique transparency on Healthcare Technology pricing and packaging.
CapSite is a healthcare technology research and advisory firm. Our mission is to help our healthcare vendor and provider clients make more informed strategic decisions. The CapSite™ database is the trusted, easy-to-use online resource, providing critical knowledge and evidence-based information on healthcare technology purchases. The CapSite database represents more than 150 healthcare technology categories and 1,500 vendors.